"Designing Growth Strategies is in our DNA"

Immunology Market Size, Share & COVID-19 Impact Analysis, By Drug Class (Monoclonal Antibody (mAb), Fusion Proteins, Immunosuppressants, and Others), By Disease Indication (Rheumatoid Arthritis, Psoriatic Arthritis, Plaque Psoriasis, Ankylosing Spondylitis, Inflammatory Bowel Disease, Prophylaxis of Organ Rejection, and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and Regional Forecast, 2022-2029

Region : Global | Format: PDF | Report ID: FBI100657

 

  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
    4. Market Trends
  4. Key Insights
    1. Prevalence of Key Disease, by Key Region (2021)
    2. Key Industry Developments (Mergers, Acquisitions & Partnerships)
    3. New Product Launches, Key Players
    4. Impact of COVID-19 on Global Immunology Market
  5. Global Immunology Market Analysis, Insights and Forecast, 2018-2029
    1. Market Analysis, Insights and Forecast – By Drug Class
      1. Monoclonal Antibodies
      2. Immunosuppressants
      3. Fusion Proteins
      4. Others
    2. Market Analysis, Insights and Forecast – By Disease Indication
      1. Rheumatoid Arthritis
      2. Psoriatic Arthritis
      3. Plaque Psoriasis
      4. Ankylosing Spondylitis
      5. Inflammatory Bowel Disease
      6. Prophylaxis of Organ Rejection
      7. Others
    3. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
    4. Market Analysis, Insights and Forecast – By Region
      1. North America
      2. Europe
      3. Asia Pacific
      4. Latin America
      5. Middle East & Africa
  6. North America Immunology Market Analysis, Insights and Forecast, 2018-2029
    1. Market Analysis, Insights and Forecast – By Drug Class
      1. Monoclonal Antibodies
      2. Immunosuppressants
      3. Fusion Proteins
      4. Others
    2. Market Analysis, Insights and Forecast – By Disease Indication
      1. Rheumatoid Arthritis
      2. Psoriatic Arthritis
      3. Plaque Psoriasis
      4. Ankylosing Spondylitis
      5. Inflammatory Bowel Disease
      6. Prophylaxis of Organ Rejection
      7. Others
    3. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
    4. Market Analysis, Insights and Forecast – By Country
      1. U.S.
      2. Canada
  7. Europe Immunology Market Analysis, Insights and Forecast, 2018-2029
    1. Market Analysis, Insights and Forecast – By Drug Class
      1. Monoclonal Antibodies
      2. Immunosuppressants
      3. Fusion Proteins
      4. Others
    2. Market Analysis, Insights and Forecast – By Disease Indication
      1. Rheumatoid Arthritis
      2. Psoriatic Arthritis
      3. Plaque Psoriasis
      4. Ankylosing Spondylitis
      5. Inflammatory Bowel Disease
      6. Prophylaxis of Organ Rejection
      7. Others
    3. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
    4. Market Analysis, Insights and Forecast – By Country/ Sub-region
      1. U.K
      2. Germany
      3. France
      4. Spain
      5. Italy
      6. Scandinavia
      7. Rest of Europe
  8. Asia Pacific Immunology Market Analysis, Insights and Forecast, 2018-2029
    1. Market Analysis, Insights and Forecast – By Drug Class
      1. Monoclonal Antibodies
      2. Immunosuppressants
      3. Fusion Proteins
      4. Others
    2. Market Analysis, Insights and Forecast – By Disease Indication
      1. Rheumatoid Arthritis
      2. Psoriatic Arthritis
      3. Plaque Psoriasis
      4. Ankylosing Spondylitis
      5. Inflammatory Bowel Disease
      6. Prophylaxis of Organ Rejection
      7. Others
    3. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
    4. Market Analysis, Insights and Forecast – By Country/ Sub-region
      1. Japan
      2. China
      3. India
      4. Australia
      5. Southeast Asia
      6. Rest of Asia Pacific
  9. Latin America Immunology Market Analysis, Insights and Forecast, 2018-2029
    1. Market Analysis, Insights and Forecast – By Drug Class
      1. Monoclonal Antibodies
      2. Immunosuppressants
      3. Fusion Proteins
      4. Others
    2. Market Analysis, Insights and Forecast – By Disease Indication
      1. Rheumatoid Arthritis
      2. Psoriatic Arthritis
      3. Plaque Psoriasis
      4. Ankylosing Spondylitis
      5. Inflammatory Bowel Disease
      6. Prophylaxis of Organ Rejection
      7. Others
    3. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
    4. Market Analysis, Insights and Forecast – By Country/Sub-region
      1. Brazil
      2. Mexico
      3. Rest of Latin America
  10. Middle East & Africa Immunology Market Analysis, Insights and Forecast, 2018-2029
    1. Market Analysis, Insights and Forecast – By Drug Class
      1. Monoclonal Antibodies
      2. Immunosuppressants
      3. Fusion Proteins
      4. Others
    2. Market Analysis, Insights and Forecast – By Disease Indication
      1. Rheumatoid Arthritis
      2. Psoriatic Arthritis
      3. Plaque Psoriasis
      4. Ankylosing Spondylitis
      5. Inflammatory Bowel Disease
      6. Prophylaxis of Organ Rejection
      7. Others
    3. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
    4. Market Analysis, Insights and Forecast – By Country/Sub-region
      1. GCC
      2. South Africa
      3. Rest of Middle East & Africa
  11. Competitive Analysis
    1. Global Market Share Analysis (2021)
    2. Company Profiles (Overview, Product, SWOT Analysis, Recent Developments, Strategies, financials (Based on Availability))
      1. Pfizer Inc.
        1. Overview,
        2. Product,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (Based on Availability)
      2. F. Hoffmann-La Roche Ltd.
        1. Overview,
        2. Product,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (Based on Availability)
      3. AbbVie Inc.
        1. Overview,
        2. Product,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (Based on Availability)
      4. Bristol-Myers Squibb Company
        1. Overview,
        2. Product,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (Based on Availability)
      5. Eli Lilly and Company
        1. Overview,
        2. Product,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (Based on Availability)
      6. UCB S.A.
        1. Overview,
        2. Product,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (Based on Availability)
      7. Amgen Inc.
        1. Overview,
        2. Product,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (Based on Availability)
      8. Merck & Co., Inc.
        1. Overview,
        2. Product,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (Based on Availability)
      9. Novartis AG
        1. Overview,
        2. Product,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (Based on Availability)
      10. Other Players
        1. Overview,
        2. Product,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (Based on Availability)
Read Less

Figure 1:  Global Immunology Market Revenue Breakdown (USD billion, %) by Region, 2021 & 2029

Figure 2:  Global Immunology Market Value Share (%), by Drug Class, 2021 & 2029

Figure 3:  Global Immunology Market Value Share (%), by Disease Indication, 2021 & 2029

Figure 4:  Global Immunology Market Value Share (%), by Distribution Channel, 2021 & 2029

Figure 5:  Global Immunology Market Value (USD billion), by Region, 2021 & 2029

Figure 6:  North America Immunology Market Value (USD billion), by Drug Class, 2021 & 2029

Figure 7:  North America Immunology Market Value Share (%), by Drug Class, 2021

Figure 8:  North America Immunology Market Value (USD billion), by Disease Indication, 2021 & 2029

Figure 9:  North America Immunology Market Value Share (%), by Disease Indication, 2021

Figure 10:  North America Immunology Market Value (USD billion), by Distribution Channel, 2021 & 2029

Figure 11:  North America Immunology Market Value Share (%), by Distribution Channel, 2021

Figure 12:  North America Immunology Market Value (USD billion), By Country, 2021 & 2029

Figure 13:  North America Immunology Market Value Share (%), By Country, 2021

Figure 14:  Europe Immunology Market Value (USD billion), by Drug Class, 2021 & 2029

Figure 15:  Europe Immunology Market Value Share (%), by Drug Class, 2021

Figure 16:  Europe Immunology Market Value (USD billion), by Disease Indication, 2021 & 2029

Figure 17:  Europe Immunology Market Value Share (%), by Disease Indication, 2021

Figure 18:  Europe Immunology Market Value (USD billion), by Distribution Channel, 2021 & 2029

Figure 19:  Europe Immunology Market Value Share (%), by Distribution Channel, 2021

Figure 20:  Europe Immunology Market Value (USD billion), By Country/ Sub-region, 2021 & 2029

Figure 21:  Europe Immunology Market Value Share (%), By Country/ Sub-region, 2021

Figure 22:  Asia Pacific Immunology Market Value (USD billion), by Drug Class, 2021 & 2029

Figure 23:  Asia Pacific Immunology Market Value Share (%), by Drug Class, 2021

Figure 24:  Asia Pacific Immunology Market Value (USD billion), by Disease Indication, 2021 & 2029

Figure 25:  Asia Pacific Immunology Market Value Share (%), by Disease Indication, 2021

Figure 26:  Asia Pacific Immunology Market Value (USD billion), by Distribution Channel, 2021 & 2029

Figure 27:  Asia Pacific Immunology Market Value Share (%), by Distribution Channel, 2021

Figure 28:  Asia Pacific Immunology Market Value (USD billion), By Country/ Sub-region, 2021 & 2029

Figure 29:  Asia Pacific Immunology Market Value Share (%), By Country/ Sub-region, 2021

Figure 30:  Latin America Immunology Market Value (USD billion), by Drug Class, 2021 & 2029

Figure 31:  Latin America Immunology Market Value Share (%), by Drug Class, 2021

Figure 32:  Latin America Immunology Market Value (USD billion), by Disease Indication, 2021 & 2029

Figure 33:  Latin America Immunology Market Value Share (%), by Disease Indication, 2021

Figure 34:  Latin America Immunology Market Value (USD billion), by Distribution Channel, 2021 & 2029

Figure 35:  Latin America Immunology Market Value Share (%), by Distribution Channel, 2021

Figure 36:  Latin America Immunology Market Value (USD billion), By Country/ Sub-region, 2021 & 2029

Figure 37:  Latin America Immunology Market Value Share (%), By Country/ Sub-region, 2021

Figure 38:  Middle East & Africa Immunology Market Value (USD billion), by Drug Class, 2021 & 2029

Figure 39:  Middle East & Africa Immunology Market Value Share (%), by Drug Class, 2021

Figure 40:  Middle East & Africa Immunology Market Value (USD billion), by Disease Indication, 2021 & 2029

Figure 41:  Middle East & Africa Immunology Market Value Share (%), by Disease Indication, 2021

Figure 42:  Middle East & Africa Immunology Market Value (USD billion), by Distribution Channel, 2021 & 2029

Figure 43:  Middle East & Africa Immunology Market Value Share (%), by Distribution Channel, 2021

Figure 44:  Middle East & Africa Immunology Market Value (USD billion), By Country/ Sub-region, 2021 & 2029

Figure 45:  Middle East & Africa Immunology Market Value Share (%), By Country/ Sub-region, 2021

Figure 46:  Global Immunology Market Share (%), By Company, 2021

Table 1:  Global Immunology Market Revenue (USD billion) Forecast, by Drug Class, 2018-2029

Table 2:  Global Immunology Market Revenue (USD billion) Forecast, by Disease Indication, 2018-2029

Table 3:  Global Immunology Market Revenue (USD billion) Forecast, by Distribution Channel, 2018-2029

Table 4:  Global Immunology Market Revenue (USD billion) Forecast, by Region, 2018-2029

Table 5:  North America Immunology Market Revenue (USD billion) Forecast, by Drug Class, 2018-2029

Table 6:  North America Immunology Market Revenue (USD billion) Forecast, by Disease Indication, 2018-2029

Table 7:  North America Immunology Market Revenue (USD billion) Forecast, by Distribution Channel, 2018-2029

Table 8:  North America Immunology Market Revenue (USD billion) Forecast, By Country, 2018-2029

Table 9:  Europe Immunology Market Revenue (USD billion) Forecast, by Drug Class, 2018-2029

Table 10:  Europe Immunology Market Revenue (USD billion) Forecast, by Disease Indication, 2018-2029

Table 11:  Europe Immunology Market Revenue (USD billion) Forecast, by Distribution Channel, 2018-2029

Table 12:  Europe Immunology Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2018-2029

Table 13:  Asia Pacific Immunology Market Revenue (USD billion) Forecast, by Drug Class, 2018-2029

Table 14:  Asia Pacific Immunology Market Revenue (USD billion) Forecast, by Disease Indication, 2018-2029

Table 15:  Asia Pacific Immunology Market Revenue (USD billion) Forecast, by Distribution Channel, 2018-2029

Table 16:  Asia Pacific Immunology Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2018-2029

Table 17:  Latin America Immunology Market Revenue (USD billion) Forecast, by Drug Class, 2018-2029

Table 18:  Latin America Immunology Market Revenue (USD billion) Forecast, by Disease Indication, 2018-2029

Table 19:  Latin America Immunology Market Revenue (USD billion) Forecast, by Distribution Channel, 2018-2029

Table 20:  Latin America Immunology Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2018-2029

Table 21:  Middle East & Africa Immunology Market Revenue (USD billion) Forecast, by Drug Class, 2018-2029

Table 22:  Middle East & Africa Immunology Market Revenue (USD billion) Forecast, by Disease Indication, 2018-2029

Table 23:  Middle East & Africa Immunology Market Revenue (USD billion) Forecast, by Distribution Channel, 2018-2029

Table 24:  Middle East & Africa Immunology Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2018-2029

Booklet
  • Dec, 2022
  • 2021
  • 2018-2020
  • 147

    CHOOSE LICENSE TYPE

  • $4850
    $5850
    $7850
    Compare Licenses Book Now

Healthcare Clients

3M
abbvie
Amgen
Ansell
Fresenius
Galemed
Grifols
Ipsos
iqvia
Johnson
Jubilant
Lek
Pfizer
Roche
Siemens Healthineers
Styker
uniliver

Related Reports

Client Testimonials

“We are happy with the professionalism of your in-house research team as well as the quality of your research reports. Looking forward to work together on similar projects”

- One of the Leading Food Companies in Germany

“We appreciate the teamwork and efficiency for such an exhaustive and comprehensive report. The data offered to us was exactly what we were looking for. Thank you!”

- Intuitive Surgical

“I recommend Fortune Business Insights for their honesty and flexibility. Not only that they were very responsive and dealt with all my questions very quickly but they also responded honestly and flexibly to the detailed requests from us in preparing the research report. We value them as a research company worthy of building long-term relationships.”

- Major Food Company in Japan

“Well done Fortune Business Insights! The report covered all the points and was very detailed. Looking forward to work together in the future”

- Ziering Medical

“It has been a delightful experience working with you guys. Thank you Fortune Business Insights for your efforts and prompt response”

- Major Manufacturer of Precision Machine Parts in India

“I had a great experience working with Fortune Business Insights. The report was very accurate and as per my requirements. Very satisfied with the overall report as it has helped me to build strategies for my business”

- Hewlett-Packard

“This is regarding the recent report I bought from Fortune Business insights. Remarkable job and great efforts by your research team. I would also like to thank the back end team for offering a continuous support and stitching together a report that is so comprehensive and exhaustive”

- Global Management Consulting Firm

“Please pass on our sincere thanks to the whole team at Fortune Business Insights. This is a very good piece of work and will be very helpful to us going forward. We know where we will be getting business intelligence from in the future.”

- UK-based Start-up in the Medical Devices Sector

“Thank you for sending the market report and data. It looks quite comprehensive and the data is exactly what I was looking for. I appreciate the timeliness and responsiveness of you and your team.”

- One of the Largest Companies in the Defence Industry
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies . Privacy.
X